A detailed history of Sei Investments CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 213,901 shares of VRTX stock, worth $87.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
213,901
Previous 212,857 0.49%
Holding current value
$87.3 Million
Previous $99.8 Million 0.29%
% of portfolio
0.13%
Previous 0.14%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $480,240 - $528,034
1,044 Added 0.49%
213,901 $99.5 Million
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $633,209 - $782,674
-1,612 Reduced 0.75%
212,857 $99.8 Million
Q1 2024

May 07, 2024

SELL
$407.69 - $446.08 $59.1 Million - $64.6 Million
-144,885 Reduced 40.32%
214,469 $89.7 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $13.7 Million - $16.4 Million
-39,864 Reduced 9.99%
359,354 $146 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $100,439 - $107,650
297 Added 0.07%
399,218 $139 Million
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $44.2 Million - $49.4 Million
140,471 Added 54.35%
398,921 $140 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $52.1 Million - $59.5 Million
184,117 Added 247.69%
258,450 $81.4 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $10.6 Million - $12 Million
-37,235 Reduced 33.37%
74,333 $21.5 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $6.33 Million - $7.07 Million
23,129 Added 26.15%
111,568 $32.3 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $10.4 Million - $13 Million
44,349 Added 100.59%
88,439 $25.1 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $2.16 Million - $2.55 Million
9,761 Added 28.43%
44,090 $11.8 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $228,519 - $288,473
-1,291 Reduced 3.62%
34,329 $7.48 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $1.41 Million - $1.58 Million
-7,796 Reduced 17.96%
35,620 $6.46 Million
Q2 2021

Aug 06, 2021

SELL
$187.49 - $221.1 $512,972 - $604,929
-2,736 Reduced 5.93%
43,416 $8.74 Million
Q1 2021

May 12, 2021

SELL
$207.02 - $241.31 $6.2 Million - $7.22 Million
-29,939 Reduced 39.35%
46,152 $10.2 Million
Q4 2020

Feb 08, 2021

SELL
$207.01 - $276.09 $9.07 Million - $12.1 Million
-43,830 Reduced 36.55%
76,091 $17.9 Million
Q3 2020

Dec 04, 2020

SELL
$255.65 - $303.1 $1.17 Million - $1.39 Million
-4,592 Reduced 3.69%
119,921 $32.7 Million
Q3 2020

Nov 06, 2020

BUY
$255.65 - $303.1 $460,936 - $546,489
1,803 Added 1.47%
124,513 $33.9 Million
Q2 2020

Aug 17, 2020

SELL
$225.48 - $295.8 $2.52 Million - $3.31 Million
-11,198 Reduced 8.36%
122,710 $35.6 Million
Q2 2020

Aug 11, 2020

SELL
$225.48 - $295.8 $507,780 - $666,141
-2,252 Reduced 1.65%
133,908 $32 Million
Q1 2020

May 14, 2020

SELL
$199.77 - $247.81 $2.39 Million - $2.97 Million
-11,973 Reduced 8.08%
136,160 $32.4 Million
Q4 2019

Feb 06, 2020

SELL
$166.71 - $223.91 $1.03 Million - $1.39 Million
-6,193 Reduced 4.01%
148,133 $32.5 Million
Q3 2019

Nov 12, 2019

BUY
$166.23 - $187.09 $3.44 Million - $3.87 Million
20,690 Added 15.48%
154,326 $26.2 Million
Q2 2019

Aug 14, 2019

SELL
$164.61 - $190.37 $950,128 - $1.1 Million
-5,772 Reduced 4.14%
133,636 $24.5 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $753,485 - $896,009
4,602 Added 3.41%
139,408 $25.6 Million
Q4 2018

Feb 13, 2019

BUY
$151.91 - $192.21 $2.18 Million - $2.76 Million
14,351 Added 11.91%
134,806 $25.5 Million
Q3 2018

Nov 08, 2018

SELL
$167.73 - $192.74 $1.88 Million - $2.16 Million
-11,228 Reduced 8.53%
120,455 $23.2 Million
Q2 2018

Aug 03, 2018

BUY
$145.72 - $169.96 $678,909 - $791,843
4,659 Added 3.67%
131,683 $22.4 Million
Q1 2018

May 11, 2018

SELL
$151.6 - $177.13 $4.76 Million - $5.56 Million
-31,375 Reduced 19.81%
127,024 $20.7 Million
Q4 2017

Feb 08, 2018

BUY
$137.28 - $155.55 $4.93 Million - $5.58 Million
35,880 Added 29.29%
158,399 $23.7 Million
Q3 2017

Nov 06, 2017

BUY
$148.13 - $162.24 $18.1 Million - $19.9 Million
122,519
122,519 $18.6 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.